There were 1,929 press releases posted in the last 24 hours and 440,424 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Supernus Pharmaceuticals to Host Webcast to Review Interim Data from Ongoing Open-Label Phase IIa Study of SPN-817 for Treatment-Resistant Seizures

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image